Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

ICON

Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research. He will oversee the growth and management of the infectious disease portfolio.

Dr. Fishbein has extensive experience in the planning and execution of clinical research in a broad range of therapeutic areas. He joined the company in 2009 from the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, MD, where he served as director of the Office for Policy in Clinical Research Operations at the NIAID’s Division of AIDS, as well as special assistant to the Deputy Director of the NIAID and senior fellow at the International Center for Research on Women. Prior to this, Dr. Fishbein held various positions at PAREXEL, including vice president of North American Medical Services.

Dr. John Hubbard, group president for Global Clinical Research Services said: “We’re delighted to welcome Dr. Fishbein to ICON Clinical Research where he will oversee the strategic development of our burgeoning infectious disease therapeutic area, which complements our well established and growing vaccine business. His wealth of clinical research experience across a broad range of therapeutic areas is a valuable asset to the team.”



Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters